Trelegy ellipta 200-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F8FE6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,249
Award facts
- Contract value 100% obligated
- $11,248.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,248.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 30, 2026, for the supply of TRELEGY ELLIPTA 200-62.5-25, a combination respiratory medication containing fluticasone furoate, umeclidinium, and vilanterol, with an ultimate completion date of February 2, 2026. The award was made without set-aside provisions, indicating full and open competition. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc. (UEI: NWEGNLYTBDW4), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the overarching vehicle for pharmaceutical and medical supply deliveries to military healthcare systems worldwide.
AmerisourceBergen is a major pharmaceutical distributor providing critical medical commodities to federal agencies, particularly the Department of Defense and military healthcare programs. The parent company, Cencora, Inc., leverages its comprehensive IDC with the DLA to supply an extensive range of pharmaceutical products, specialty medications, vaccines, and medical supplies across multiple therapeutic domains to military treatment facilities and veteran healthcare programs. This specific delivery order represents a routine replenishment of respiratory therapy medication as part of ongoing federal medical procurement needs through the established contract vehicle.
Quick answers
Who was awarded contract SPE2DR26F8FE6?
SPE2DR26F8FE6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F8FE6 worth?
The government has obligated $11,249 on SPE2DR26F8FE6.
Is contract SPE2DR26F8FE6 an order under another contract?
Yes. SPE2DR26F8FE6 is a delivery order under SPE2DR25D3110, an indefinite delivery contract.
Was contract SPE2DR26F8FE6 competed?
The extent of competition for SPE2DR26F8FE6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award